Prof. Yening Jin 金冶宁
Chief Physician, Professor
Department of Radiation Oncology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Breast cancer breast-conserving comprehensive therapy, gynecologic tumor radiochemotherapy, esophageal cancer radiochemotherapy, anal cancer, nasopharyngeal cancer radiotherapy.
Dr. Jin graduated from China Medical University in 1982. In 1987, Dr. Jin conducted tumor radiochemotherapy research at the Curie Institute in Paris, France, and earned a specialized diploma in tumor radiotherapy from Paris V University in 1990. From 1991 to 1993, Dr. Jin served as a foreign attending physician at Besancon University Medical School. Techniques include 3D conformal radiotherapy, brachytherapy, intraoperative radiotherapy, and total body irradiation.
Name order: in Chinese the family name comes first (Jin Yening). Papers usually list the name as Yening Jin or Jin Y.
Selected publications
12 papers on PubMed matched by name and affiliation; 0 as first or senior author since 2016. Most recent first- or senior-author papers:
- J Laparoendosc Adv Surg Tech A, 2013 (senior author): Laparoscopic resection with intraoperative radiotherapy for local advanced rectal cancer: a preliminary case report. PubMed 23272726
- Zhonghua Zhong Liu Za Zhi, 2012 (senior author): [Essential role of TRPC6 in the proliferation of gastric cancer and its mechanism]. PubMed 23158989
- J Surg Oncol, 2011 (senior author): Using detection of survivin-expressing circulating tumor cells in peripheral blood to predict tumor recurrence following curative resection of gastric cancer. PubMed 21259243
- Jpn J Clin Oncol, 2009 (senior author): A phase II study of paclitaxel and nedaplatin as first-line chemotherapy in patients with advanced esophageal cancer. PubMed 19509000
- Anticancer Drugs, 2009 (senior author): Phase II trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) as first-line treatment for advanced gastric cancer. PubMed 19177020
- Ai Zheng, 2007 (senior author): [Effect of gefitinib on radiosensitivity of gastric cancer cell lines]. PubMed 18076795
- Zhonghua Zhong Liu Za Zhi, 2007 (senior author): [Evaluation of preoperative radiotherapy or chemoradiotherapy in sphincter preservation for locally advanced middle-low rectal cancer]. PubMed 17649643
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion